Skip to main content
. 2023 May 27;15(11):2946. doi: 10.3390/cancers15112946

Figure 3.

Figure 3

Multivariable stratified analyses of the association between daily aspirin and the risk of hepatocellular carcinoma. Comparison of the risk of hepatocellular carcinoma between the aspirin users (≥84 days) and nonusers. Dark circles: OR; horizontal lines: 95% confidence intervals.